Page 114

219. Waxman SG. 1998. Demyelinating diseases—new pathological insights, new therapeutic targets. N Engl J Med.; 338: 323-5..

220. Waxman SG. 2000. Multiple sclerosis as a neuronal disease. Arch Neurol.; 57: 22-4..

221. Waxman SG, Black JA, Sontheimer H, Kocsis JD. 1994. Glial cells and axo-glial interactions: implications for demyelinating disorders. Clin Neurosci.; 2: 202-10..

222. Weinshenker BG, Bass B, Rice GP, et al. 1989. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain.; 112: 133-46..

223. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. 1999. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology.; 52: 1626-32..

224. Whitacre CC, Reingold SC, O'Looney PA. 1999. A gender gap in autoimmunity. Science.; 283: 1277-8..

225. Williams KC, Ulvestad E, Hickey WF. 1994. Immunology of multiple sclerosis. Clin Neurosci.; 2: 229-45..

226. Wong FS, Dittel BN, Janeway CA Jr. 1999. Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis. Immunol Rev.; 169: 93-104..

227. Wong FS, Janeway CA Jr. 1999. Insulin-dependent diabetes mellitus and its animal models. Curr Opin Immunol.; 11: 643-647..

228. Wucherpfennig KW, Hafler DA. 1995. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Ann N Y Acad Sci 1995 Jul 7;756:241-58.; 756: 241-58..

229. Wucherpfennig KW, Strominger JL. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell.; 80: 695-705..

230. Xu Z, Cork LC, Griffin JW, Cleveland DW. 1993. Involvement of neurofilaments in motor neuron disease. J Cell Sci Suppl.; 17: 101-8..

231. Yamasaki K, Horiuchi I, Minohara M, et al. 1999. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain.; 122: 1689-96..

232. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med.; 179: 973-84..

233. Zhang J, Stinissen P, Medaer R, Truyen L, Raus J. 1998. T-cell vaccination for the treatment of multiple sclerosis. In Zhang J, editor. Immunotherapy in Neuroimmunologic Diseases. London, England. Martin Dunitz.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement